50bio.Comsp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2018-04-09. Active
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | —— | Prezydent Miasta Stołecznego Warszawy |
Tenders
5 tenders recorded as contractor: 1 national ($53,581) and 4 EU ($1,604,853).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Sep 22, 2025 | Usługa monitorowania badania klinicznego oraz wsparcia merytorycznego w związku z realizacją projektu pn. „Wpływ sakubitrylu/walsartanu w porównaniu z ramiprylem na przebudowę i funkcję lewej komory u pacjentów z niewydolnością serca o etiologii niedokrwiennej i pośrednią frakcją wyrzutową” akronim CRACOVIA-HF (2019/ABM/1/00049) | $141.8K$141,838 | Krakowski Szpital Specjalistyczny Im. Św. Jana Pawła II | |
| Dec 16, 2024 | Kompleksowy nadzór nad realizacją badania klinicznego | $296.5K$296,549 | Narodowy Instytut Geriatrii,Reumatologii I Rehabilitacji Im. Prof. Dr Hab. Med. Eleonory Reicher | |
| Aug 19, 2024 | 20.2024 Monitorowanie eksperymentu medycznego AIDA wraz z dostawą i obsługą systemu eCRF dla Katedry i Kliniki Hematologii, Nowotworów Krwi i Transplantacji Szpiku Uniwersytetu Medycznego we Wrocławiu | $1.0M$1,047,540 | Uniwersytet Medyczny Im. Piastów Śląskich we Wrocławiu |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Bartosz Arkady Maciejewski (29) | 45 | $607.78 | 45% |
Konrad Henryk Maciejewski (55) | 55 | $742.84 | 55% |
Konrad Henryk Maciejewski and Bartosz Arkady Maciejewski hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights | |
|---|---|---|
Bartosz Arkady Maciejewski (29) | Shareholder of a limited liability company, 2250.0 PLN | |
Konrad Henryk Maciejewski (55) | Shareholder of a limited liability company, 2750.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Satagrosp. z o.o. | $1,365,254.65 | satagro.pl | ||
| Instytut Materiałów Budowlanych i Technologii Betonusp. z o.o. | $948,903.87 | imbitb.pl | ||
| DR Koziejsp. z o.o. + limited partnership | $770,078.78 | drkoziej.com | ||
| Florabosp. z o.o. | $765,897.40 | florabo.pl | ||
| Retailicsp. z o.o. | $637,675.32 | retailic.com | ||
| EkoparkS.A. | $585,284.10 | eko-park.org | ||
| CTI Clinical Trial And Consulting Services Polandsp. z o.o. | $527,145.56 | ctifacts.com | ||
| Unia Producentów I Pracodawców Przemysłu Biogazowego I BiometanowegoEmployers' association | $480,518.70 | upebi.pl | ||
| Lemontechsp. z o.o. | $451,765.45 | lemontech.com.pl | ||
| Nevomo Polandsp. z o.o. | $315,353.55 | nevomo.tech |
Change history
| Date | Event | |
|---|---|---|
| 2019-12-19 | PKD change (Removed: 72.11.Z; Added: 47.74.Z, 68.20.Z, 78.30.Z, 82.20.Z, 86.10.Z, 86.21.Z, 86.22.Z, 86.90) | |
| 2018-03-14 | Entered in the register |
FAQ
Last updated: 2026-09-14
